The ACME Laboratories Limited
78.20
BDT
-0.10
-0.13%
Last updated on 16 Mar, 13:51
Today
-0.13%
1 Week
1.56%
1 Month
-4.98%
6 Month
-2.13%
1 Year
6.39%
5 Year
10.76%
Matket Today
Open
78.3
BDT
Low
77.9
BDT
High
78.7
BDT
Volume
211047
Value
1.65
Crore
Trade
485
YCP
78.3
BDT
52W Low
67.9
BDT
52W High
85.9
BDT
Circuit Low
70.5
BDT
Circuit Up
86.1
BDT
Beta (1 Year)
0.84
Financial Indicators
P/E ratio
6.40
EPS (TTM)
12.22
NAV (Q2 2026)
128.97
Total Shares
21.16
Crore
Shot-term loan
1773.52
Crore
Long-term loan
707.49
Crore
Market Capital
1656.84
Crore
Paid-up Capital
211.60
Crore
Authorized Capital
500
Crore
Last AGM Date
22 Dec 2025
Last Record Date
18 Nov 2025
Year End
30-Jun
About The ACME Laboratories Limited
Sector
Pharmaceuticals & Chemicals
Listing Year
2016
cs@acmeglobal.com
The company is currently producing over 800 products in various dosage forms, covering a wide range of therapeutic categories such as anti-infective, cardiovascular, antidiabetics, gastrointestinal, CNS, respiratory diseases, hormones, steroids, and more. With a strong presence in the local market, the company has expanded its reach to international markets, establishing a firm presence in South East Asia, Africa, and Central America. The commitment of over 7000 employees, combined with knowledge and professionalism, has enabled continuous improvement in facilities, capabilities, and product portfolios. The company is dedicated to enhancing the quality of life for patients, supporting the success of customers, and addressing global healthcare challenges.